Tilray Brands (TLRY) Enterprise Value Growth (1y) (2018 - 2026)
Tilray Brands (TLRY) Enterprise Value Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | Tilray Brands | 541.05 Mn | 306.41 Mn | 90.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | 8.68% |
| Nov 30, 2025 | -19.63% |
| Aug 31, 2025 | -3.71% |
| May 31, 2025 | -6.92% |
| Nov 30, 2024 | -15.67% |
| Aug 31, 2024 | 37.94% |
| May 31, 2024 | 40.07% |
| Feb 29, 2024 | 40.35% |
| Nov 30, 2023 | 44.19% |
| Aug 31, 2023 | 2.24% |
| May 31, 2023 | -16.32% |
| Feb 28, 2023 | -65.08% |
| Nov 30, 2022 | -42.55% |
| Aug 31, 2022 | -46.06% |
| May 31, 2022 | 22.58% |
| May 31, 2021 | -44.51% |
| Mar 31, 2020 | 40.37% |
| Dec 31, 2019 | 76.37% |
| Sep 30, 2019 | -22.24% |
| Dec 31, 2018 | -22,181.10% |